Back to search

Poland· PL-100466713

Diclofenac Dr.Max

A diclofenac product containing diclofenacum diethylammonium, registered in Poland by Dr. Max Pharma s.r.o.. The same ATC class is registered in 14 of our 19 countries.

ATC M02AA15

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedDiclofenac Dr.MaxATCM02AA15REGISTER NO.PL-100466713PACKS LISTED6CHECKEDSeptember 27, 2026

Where it is registered

Diclofenac is registered in 14 of 19 countries.

Countries holding a registration under ATC M02AA15 (diclofenac), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 8 of them publish a price we can compare per daily dose

Diclofenac · ATC M02AA15

14 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Germany
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of diclofenac costs, country by country.

Normalised to the WHO defined daily dose (0.1 g), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Diclofenac · price per daily dose (0.1 g)

USD · FX 28 Sept 2026

  • CH Switzerland$1.43
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

URPL (Poland)
Active substance
Diclofenacum diethylammonium
Manufacturer
Dr. Max Pharma s.r.o.
Country
Poland (PL)
ATC code
M02AA15
ATC class
Diclofenac
Defined daily dose
0.1 g, T
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 6

  • gtin
    08595566457846
  • gtin
    08595566457853
  • gtin
    08595566457877
  • gtin
    08595566457884
  • gtin
    08595566457839
  • gtin
    08595566457860

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

131 interactions on record for diclofenac.

Graded by severity as the source publishes them — 9 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Diclofenac · interactions on record

131 records

  • 9 severe
  • 122 moderate

Most severe, free to view

  • MipomersenC10AX11severe
  • LomitapideC10AX12severe
  • PexidartinibL01EX15severe
  • LeflunomidL04AA13severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Diclofenac in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All diclofenac products

Authorised across Europe · EMA

The same active substance is authorised in 29 EEA countries. Names it is sold under:

  • Austria · Dedolor Akut, Dedolor Drs
  • Belgium · Cataflam, Dicloabak
  • Bulgaria · Diclofenac-Tchaikapharma, Алмирал
  • Cyprus · Almiral, Areston
  • Czechia · Almiral, Dicloabak
  • Germany · Arthrex Schmerzgel, Diclac
  • Denmark · Diclodan, Diclofenac Bluefish
  • Estonia · Almiral, Dagesil
  • Spain · Cinfadol, Dagesil
  • Finland · Dicloabak, Diclomex Rapid
  • France · Antalcalm, Diclamine
  • United Kingdom (Northern Ireland) · Akis, Amgesic Muscle & Back Pain Relief
  • Greece · Batafil, Denaclof
  • Croatia · Diclac Duo, Diclo Duo
  • Hungary · Algoplast, Cataflam
  • Ireland · Cataflam, Diclac
  • Iceland · Diclofenac Alvogen, Dimax
  • Italy · Brexiadvance, Dealgic
  • Lithuania · Dagesil, Diclac
  • Luxembourg · Cataflam, Dicloabak
  • Latvia · Almiral, Dagesil
  • Malta · Almiral, Areston
  • Netherlands · Areston, Dicloabak
  • Norway · Cataflam, Diclofenac Bluefish
  • Portugal · Dagesil, Dicipan
  • Romania · Almiral, Clafen
  • Sweden · Dicloabak, Diclofenac Bluefish
  • Slovenia · Diclo Duo, Dicloflex
  • Slovakia · Akis Plus, Almiral

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/b84119f2-41cc-40fa-abd5-2f4c72b64485
GET /v1/drugs/b84119f2-41cc-40fa-abd5-2f4c72b64485?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Żel",
  "source": "urpl",
  "strength": "23,2 mg/g",
  "packaging": "08595566457846 ¦ OTC ¦ 159187\n1 tuba 50 g\n08595566457853 ¦ OTC ¦ 159188\n1 tuba 60 g\n08595566457877 ¦ OTC ¦ 159189\n1 tuba 150 g\n08595566457884 ¦ OTC ¦ 159190\n1 tuba 180 g\n08595566457839 ¦ OTC ¦ 159191\n1 tuba 30 g\n08595566457860 ¦ OTC ¦ 159192\n1 tuba 100 g",
  "substance": "Diclofenacum diethylammonium 23.2 mg/g",
  "common_name": "Diclofenacum diethylammonium",
  "pl_product_id": "100466713",
  "pozwolenie_nr": "28711",
  "auth_procedure": "DCP",
  "authorisation_validity": "2029-11-19"
}

See everything about diclofenac.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.